Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (851-860 of 982) with videos related to

Pageof 99
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
Development of the first prediction model for radiation-induced contrast enhancement after proton therapy for posterior fossa tumours in paediatric patientsAbel Bregman, Jikke J Rutgers, Truls Andersen, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 1998
Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995A J de Neeling, W J van Leeuwen, L M Schouls, et al.
The Journal of Pathology|October 4, 2023
Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancerNelleke Pm Brouwer, Loth Webbink, Tariq S Haddad, et al.
Journal of the National Cancer Institute|September 20, 2017
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.
Breast Cancer Research and Treatment|April 25, 2014
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithmsC A Drukker, M V Nijenhuis, J M Bueno-de-Mesquita, et al.
Communications Biology|July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trialLaurent Jacob, Anke Witteveen, Inès Beumer, et al.
Journal of the National Cancer Institute|September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerMarc Buyse, Sherene Loi, Laura van't Veer, et al.
Breast Cancer Research and Treatment|September 22, 2011
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniquesBas B Koolen, Marie-Jeanne T F D Vrancken Peeters, Tjeerd S Aukema, et al.
Nutrition and Cancer|April 30, 2008
Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer riskDorien W Voskuil, Alina Vrieling, Catharina M Korse, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
Pageof 99

Showing results (851-860 of 982) with videos related to

Sort By:
Pageof 99
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
Development of the first prediction model for radiation-induced contrast enhancement after proton therapy for posterior fossa tumours in paediatric patientsAbel Bregman, Jikke J Rutgers, Truls Andersen, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 1998
Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995A J de Neeling, W J van Leeuwen, L M Schouls, et al.
The Journal of Pathology|October 4, 2023
Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancerNelleke Pm Brouwer, Loth Webbink, Tariq S Haddad, et al.
Journal of the National Cancer Institute|September 20, 2017
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)Erik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.
Breast Cancer Research and Treatment|April 25, 2014
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithmsC A Drukker, M V Nijenhuis, J M Bueno-de-Mesquita, et al.
Communications Biology|July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trialLaurent Jacob, Anke Witteveen, Inès Beumer, et al.
Journal of the National Cancer Institute|September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerMarc Buyse, Sherene Loi, Laura van't Veer, et al.
Breast Cancer Research and Treatment|September 22, 2011
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniquesBas B Koolen, Marie-Jeanne T F D Vrancken Peeters, Tjeerd S Aukema, et al.
Nutrition and Cancer|April 30, 2008
Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer riskDorien W Voskuil, Alina Vrieling, Catharina M Korse, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
Pageof 99